Clinical trials
Recruiting Smoldering Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Regeneron Pharmaceuticals | 2 |
| University of Miami | 2 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Ciceri Fabio | 1 |
| Dana-Farber Cancer Institute | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Emory University | 1 |
| European Myeloma Network B.V. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Smoldering Multiple Myeloma | 28 |
| Multiple Myeloma | 16 |
| Monoclonal Gammopathy of Undetermined Significance | 14 |
| Immunoglobulin Light-chain Amyloidosis | 3 |
| Leukemia, Plasma Cell | 3 |
| Amyloidosis | 2 |
| Castleman Disease | 2 |
| Cryoglobulinemia | 2 |
| POEMS Syndrome | 2 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.